[
  {
    "ts": null,
    "headline": "Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.",
    "url": "https://finnhub.io/api/news?id=1173ea784fa0d83a59a3829aadfba5eaa4af4302dccb2ab23afafc2f7ddac2e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759262739,
      "headline": "Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know",
      "id": 136944578,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.",
      "url": "https://finnhub.io/api/news?id=1173ea784fa0d83a59a3829aadfba5eaa4af4302dccb2ab23afafc2f7ddac2e3"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne (TECH) Shares Skyrocket, What You Need To Know",
    "summary": "Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 5.3% in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.",
    "url": "https://finnhub.io/api/news?id=bb534231d94ab70141e1accb19adf55ceef89b1f2b3945195b7aa1a3a4abd0c6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759262442,
      "headline": "Bio-Techne (TECH) Shares Skyrocket, What You Need To Know",
      "id": 136944697,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 5.3% in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.",
      "url": "https://finnhub.io/api/news?id=bb534231d94ab70141e1accb19adf55ceef89b1f2b3945195b7aa1a3a4abd0c6"
    }
  }
]